GlassScriptPhysician profile
Dwayne Edward Johnson
NPI 1841379187
$1,733.11
in general payments reported to CMS, 2019-2025
15 companies · $93.36 in 2025
The $93.36 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $57.82 · 2020: $44.47 · 2021: $540 · 2022: $670 · 2023: $188 · 2024: $140 · 2025: $93.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $421.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.60 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Welch Allyn | $348.33 | 2021 | |
| Global Blood Therapeutics, INC. | $247.06 | 2022 | |
| Glaxosmithkline, LLC. | $246.78 | 2019-2025 | Bexsero, Pediarix, Rotarix |
| Baxter Healthcare | $241.48 | 2022 | |
| Merck Sharp & Dohme LLC | $198.60 | 2021-2025 | Vaxelis, Gardasil 9, Vaxneuvance |
| Dexcom, INC. | $129.98 | 2021-2025 | Dexcom G6 Transmitter |
| Gilead Sciences, INC. | $87.30 | 2019-2025 | |
| Sanofi Pasteur INC. | $67.04 | 2022-2023 | |
| Pfizer INC. | $53.93 | 2021-2024 | |
| Teva Pharmaceuticals USA, INC. | $23.00 | 2019-2020 | |
| Lilly USA, LLC | $22.87 | 2024 | Jardiance |
| Sobi, INC | $18.75 | 2019 | |
| Insulet Corporation | $16.65 | 2022 | |
| Abbott Laboratories | $16.54 | 2022 | |
| Novartis Pharmaceuticals Corporation | $14.80 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dwayne Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.